US Broker Ratings

AnaptysBio, Inc. (ANAB) Investor Outlook: Exploring a Potential 126% Upside

AnaptysBio, Inc. (NASDAQ: ANAB) is capturing investor attention with its impressive potential upside of 126.03%, according to recent analyst ratings. As a clinical-stage biotechnology firm, AnaptysBio..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring 234% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA) has been capturing the attention of investors in the healthcare sector, particularly within the biotechnology industry. This San Diego-based clinical-stage biopharmaceutical..

HealthStream, Inc. (HSTM) Stock Analysis: Evaluating a 21.08% Potential Upside in Healthcare SaaS

HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the healthcare information services sector, offers a unique investment opportunity with a potential upside of 21.08%. As a..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a 39% Upside in a Challenging Market

Cross Country Healthcare, Inc. (NASDAQ: CCRN) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of..

Castle Biosciences, Inc. (CSTL) Investor Outlook: Unpacking a 51.85% Potential Upside

Castle Biosciences, Inc. (NASDAQ: CSTL), a prominent player in the healthcare sector, specifically in diagnostics and research, is generating buzz among investors with its robust potential..

InnovAge Holding Corp. (INNV) Stock Analysis: Evaluating a 30.55% Potential Upside in the Healthcare Sector

InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, specifically within the medical care facilities industry, is currently navigating a complex landscape. With..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating a Challenging Healthcare Staffing Market

AMN Healthcare Services Inc (AMN), a notable player in the healthcare sector, is grappling with a challenging landscape within the medical care facilities industry. With a..

Opthea Limited (OPT): Investor Outlook on Potential Downside and Strategic Focus

Opthea Limited (OPT) stands at a pivotal juncture as it navigates the challenging waters of the biotechnology sector. With a market capitalization of approximately $524.82 million,..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Unpacking the 14.99% Potential Upside

Fulgent Genetics, Inc. (NASDAQ: FLGT), a player in the diagnostics and research industry within the healthcare sector, has captured investor attention with a notable potential upside..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Biotech Terrain with a Cautious Eye

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to cell programming. Headquartered in..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Report: Analyst Consensus Points to 34% Upside Potential

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is a burgeoning player in the biotechnology sector that is capturing investor attention with its promising pipeline targeting neurodegenerative diseases and..

Talkspace, Inc. (TALK) Stock Analysis: Unlocking an 80% Potential Upside in the Virtual Healthcare Arena

For investors with an eye on the burgeoning field of digital health, Talkspace, Inc. (NASDAQ: TALK) presents a compelling opportunity. As a leader in virtual behavioral..

Nurix Therapeutics, Inc. (NRIX) Investor Outlook: Evaluating a 217% Potential Upside

Nurix Therapeutics, Inc. (NASDAQ: NRIX), a clinical-stage biopharmaceutical company, is currently making waves in the biotechnology sector with its innovative small molecule and antibody therapies aimed..

Beta Bionics, Inc. (BBNX) Stock Analysis: Exploring a 26.49% Potential Upside in the Medical Device Sector

Beta Bionics, Inc. (NASDAQ: BBNX) is capturing the attention of investors with its innovative approach to diabetes care. As a commercial-stage medical device company, Beta Bionics..

Anavex Life Sciences Corp. (AVXL): Healthcare Stock with a Compelling 272% Potential Upside

Anavex Life Sciences Corp. (NASDAQ: AVXL) is positioned on the cutting edge of biotechnology, focusing on therapies for neurodegenerative, neurodevelopmental, and neuropsychiatric disorders. With a current..

Upstream Bio, Inc. (UPB) Stock Analysis: 196% Potential Upside and Strong Buy Ratings Ignite Investor Interest

Upstream Bio, Inc. (NASDAQ: UPB), a promising player in the biotechnology sector, is capturing investor attention with its impressive potential upside and strong buy ratings. As..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Potential 102.60% Upside Captures Investor Attention

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a burgeoning name in the biotechnology sector, is drawing significant investor interest with its substantial potential upside. Based in Boulder, Colorado,..

Cronos Group Inc. (CRON) Stock Analysis: A Healthcare Player with Growth Potential Amidst Market Volatility

Cronos Group Inc. (NASDAQ: CRON) is a noteworthy player in the healthcare sector, specifically within the drug manufacturers – specialty and generic industry. Based in Stayner,..

Eton Pharmaceuticals, Inc. (ETON) Investor Outlook: Aiming for a 73.61% Upside with Robust Revenue Growth

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is making waves in the healthcare sector, particularly within the niche of drug manufacturing for specialty and generic drugs. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds